Public Release: 

Halting Parkinson's disease-related neurodegeneration

Proceedings of the National Academy of Sciences

Researchers report the identification of a small molecule called SynuClean-D, which disrupts amyloid fibrils and inhibits the aggregation of α-synuclein, both of which are pathogenic processes in Parkinson's disease; in trials using animal neurodegeneration models, SynuClean-D reduced the toxicity of α-synuclein, prevented amyloid fiber propagation, and reversed degeneration of dopaminergic neurons, suggesting that SynuClean-D may represent a possible therapeutic for neurodegeneration.


Article #18-04198: "Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons," by Jordi Pujols et al.

MEDIA CONTACT: Salvador Ventura, Universitat Autonoma de Barcelona, SPAIN; e-mail:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.